TriSalus Life Sciences, Inc. (TLSI) shares gained 13.36 percent to $5.22, up $0.61 on Friday, after the company announced the pricing of its previously disclosed underwritten public offering of common stock expected to generate approximately $40.0 million in gross proceeds.
The stock is currently trading at $5.11, compared with a previous close of $4.61. It opened at $4.91 and has traded between $4.91 and $5.47 during the session on the Nasdaq. Trading volume stands at 0.27 million shares, above its average volume of 0.17 million shares.
TriSalus priced 9,756,100 shares at $4.10 per share and granted the underwriter a 30-day option to purchase up to an additional 1,463,415 shares. The offering is expected to close on or about February 23, 2026.
The stock has traded within a 52-week range of $3.42 to $7.95.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.